Outset Medical Inc   (OM)
Other Ticker:  
Price: $5.6900 $0.45 8.588%
Day's High: $5.7 Week Perf: 13.12 %
Day's Low: $ 5.19 30 Day Perf: 51.33 %
Volume (M): 808 52 Wk High: $ 30.55
Volume (M$): $ 4,596 52 Wk Avg: $17.86
Open: $5.27 52 Wk Low: $2.90

 Market Capitalization (Millions $) 283
 Shares Outstanding (Millions) 50
 Employees 500
 Revenues (TTM) (Millions $) 131
 Net Income (TTM) (Millions $) -176
 Cash Flow (TTM) (Millions $) -58
 Capital Exp. (TTM) (Millions $) 5

Outset Medical Inc
Outset Medical Inc. is a pioneering medical technology company that offers innovative solutions for the delivery of hemodialysis treatment. The company was founded in 2003 by Leslie Trigg, who was inspired to create a better experience for hemodialysis patients after witnessing her father's struggles with the treatment.

Outset Medical's flagship product is the Tablo Hemodialysis System, which streamlines the hemodialysis process by integrating multiple functions that are typically performed by separate machines. Tablo consists of a small, mobile machine that can be used in hospitals, clinics, and patients' homes. The system can automatically monitor and adjust dialysis parameters, and it can also generate real-time diagnostic information that can help providers make more informed decisions about patient care.

Tablo is designed to be easy to use, and it features a touch-screen interface that guides patients and providers through the treatment process. In addition, Tablo is designed to minimize the use of consumables, reduce water usage, and lower treatment costs.

Outset Medical has received significant recognition for its innovative technology. In 2021, the company was named one of Fast Company's Most Innovative Companies in the Biotech category. In addition, the Tablo Hemodialysis System has received FDA clearance and is currently used in clinics across the United States.

The company has also attracted significant investment, raising $277 million in a Series D funding round in 2020. Outset Medical is headquartered in San Jose, California, and has additional offices in Minnesota and Georgia. The company has a team of over 400 employees and is continuing to grow as they expand their offerings and bring better medical solutions to the industry.

   Company Address: 3052 Orchard Dr. San Jose 95134 CA
   Company Phone Number: 231-8200   Stock Exchange / Ticker: NASDAQ OM
   OM is expected to report next financial results on February 12, 2024.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Aurora Technology Acquisition Corp

ATAK, contraction in the operating behavior throughout the July to September 30 2023 period

While the earnings season of the July to September 30 2023 continues, many businesses have reported the earnings. Among them, have been many corporations in the Medical Equipment and Supplies industry. And now, ATAK issued operating deficit of $-0.4793 million, for the third quarter of 2023 earnings season.

Vivos Therapeutics Inc

Vivos Therapeutics Inc. Defies Financial Odds in the Demanding Times of September 2023

For the fiscal time-frame closing September 30 2023 Vivos Therapeutics Inc decreased a loss per share of $-1.75 per share compare to $-6.50 a year before and Income per Share improved from $-4.50 per share from the preceding reporting season. The revenue crumbled by -31.748 % to $2.90 million from $4.25 million in the corresponding reporting season a year before and sequentially Revenue decreased by -6.456 % from $3.10 million.

Vystar Corporation

Devastating Blow: Medical Equipment and Supplies Company Suffers Major Setback in Q3 2023 Financial Report

For the financial interval ending September 30 2023 Vystar Corporation decreased a loss per share of $-0.03 per share compare to $-0.23 a year prior and Income per Share improved from $-0.04 per share from the previous reporting season. The revenue went down sharply by -98.311 % to $0.06 million from $3.57 million in the comparable reporting season a year prior and sequentially revenue surged by 67.054 % from $0.04 million. The remainder ofMedical Equipment and Supplies sector, posted a revenue improvement in the third quarter of 2023.

Petvivo Holdings Inc

Petvivo Holdings Inc Experiences Widening Losses in Q2 2024 Amid Decrease in Orders

As an investor closely following Petvivo Holdings Inc, the recent financial results have presented a mixed bag of challenges and opportunities. In the second quarter of 2024, the company experienced lower turnover, resulting in a significant revenue decrease and a larger shortfall per share compared to the previous year. However, there were notable signs of potential growth and increasing demand within the Medical Equipment and Supplies industry.
One of the key financial indicators is the revenue, which decreased by -7.127% to $0.21 million year on year. This decline is concerning for Petvivo Holdings Inc, as it points to potential shortcomings in the company's ability to generate sales. Comparatively, the Medical Equipment and Supplies industry as a whole recorded a top-line rise in the same period, suggesting that Petvivo may be facing certain internal challenges.

Ir Med Inc

Ir Med Inc announced operating profit of $1.197 million, in the third quarter of 2023 financial report

As an observer of the Medical Equipment and Supplies sector, I have thoroughly analyzed the third quarter financial results of Ir Med Inc. The company's performance took center stage in this report, overshadowing the same period in the previous year. Despite operating predominantly in the development phase, Ir Med Inc showcased a bullish quarter, signaling potential growth prospects.
Notably, Ir Med Inc reported an operating profit of $1.197 million for the July to September 30, 2023 quarter, without any reported revenue. This indicates that the company is focusing on developing its services rather than generating immediate revenue. Such a strategic course of action is crucial for a business aiming to establish a strong foundation before entering the market.


Outset Medical Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com